Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. Price to Sales Ratio (P/S) on February 07, 2025: 1.39

Fukuda Denshi Co., Ltd. Price to Sales Ratio (P/S) is 1.39 on February 07, 2025, a -11.72% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Fukuda Denshi Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 1.63 on September 13, 2024, which is 17.06% above the current Price to Sales Ratio (P/S).
Fukuda Denshi Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 1.15 on June 17, 2024, which is -16.94% below the current Price to Sales Ratio (P/S).
Fukuda Denshi Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.38.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years